Neuroprotective Influence of miR-301a Inhibition in Experimental Cerebral Ischemia/Reperfusion Rat Models Through Targeting NDRG2
- 49 Downloads
The objective of this study is to find out the potential influence of miR-301a in an experimental cerebral ischemia-reperfusion (I/R) rat model through targeting NDRG2. Rats with cerebral I/R injury were constructed and classified into model, miR-301a inhibitor, miR-301a mimic, NC (negative control), siNDRG2, NDRG2, and miR-301a inhibitor + si-NDRG2 groups, as well as another sham group. Cerebral infarct volume and cell apoptosis were observed by TTC staining and TUNEL staining. The targeting relationship between miR-301a and NDRG2 was verified by luciferase assay. ELISA, qRT-PCR, and Western blot were used to detect the expressions of related molecules. Compared with sham group, rats in the model group had elevated neurological function score and infarct volume; meanwhile, the cell apoptosis rate and inflammatory response were also increased with enhanced expression of miR-301a and NDRG2 (all P < 0.05). These changes were worsened in the miR-301a mimic and si-NDRG2 groups. Conversely, those rats in the miR-301a inhibitor and NDRG2 groups presented increased NDRG2, and at the same time, other above concerning factors also exhibited opposite tendencies (all P < 0.05). Dual-luciferase reporter gene assay confirmed that NDRG2 was a target gene of miR-301a, and si-NDRG2 could reverse the neuroprotective effect of miR-301a inhibitor in rats with cerebral I/R injury. Inhibiting miR-301a has a neuroprotective effect on rats with cerebral I/R injury to ameliorate cell apoptosis and inflammatory response through possibly targeting NDRG2.
KeywordsCerebral ischemia-reperfusion injury miR-301a NDRG2 Apoptosis
We appreciate all the reviewers for their suggestions and comments.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- Bayne K (1996) Revised guide for the care and use of laboratory animals available. American Physiological Society Physiologist 39(199):208–111Google Scholar
- Foletta VC, Brown EL, Cho Y, Snow RJ, Kralli A, Russell AP (2013) Ndrg2 is a PGC-1alpha/ERRalpha target gene that controls protein synthesis and expression of contractile-type genes in C2C12 myotubes. Biochim Biophys Acta 1833:3112–3123. https://doi.org/10.1016/j.bbamcr.2013.08.011 CrossRefGoogle Scholar
- Guo YJ, Liu JX, Guan YW (2016) Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting. NDRG2 Eur Rev Med Pharmacol Sci 20:101–108Google Scholar
- Korhonen P, Kanninen KM, Lehtonen Š, Lemarchant S, Puttonen KA, Oksanen M, Dhungana H, Loppi S, Pollari E, Wojciechowski S, Kidin I, García-Berrocoso T, Giralt D, Montaner J, Koistinaho J, Malm T (2015) Immunomodulation by interleukin-33 is protective in stroke through modulation of inflammation. Brain Behav Immun 49:322–336. https://doi.org/10.1016/j.bbi.2015.06.013 CrossRefGoogle Scholar
- Takarada-Iemata M, Yoshikawa A, Ta HM, Okitani N, Nishiuchi T, Aida Y, Kamide T, Hattori T, Ishii H, Tamatani T, le TM, Roboon J, Kitao Y, Matsuyama T, Nakada M, Hori O (2018) N-myc downstream-regulated gene 2 protects blood-brain barrier integrity following cerebral ischemia. Glia 66:1432–1446. https://doi.org/10.1002/glia.23315 CrossRefGoogle Scholar
- Yu HC, Bai L, Yue SQ, Wang DS, Wang L, Han H, Dou KF (2013) Notch signal protects non-parenchymal cells from ischemia/reperfusion injury in vitro by repressing ROS. Ann Hepatol 12:815–821Google Scholar
- Zhang JF, Shi LL, Zhang L, Zhao ZH, Liang F, Xu X, Zhao LY, Yang PB, Zhang JS, Tian YF (2016) MicroRNA-25 negatively regulates cerebral ischemia/reperfusion injury-induced cell apoptosis through Fas/FasL pathway. J Mol Neurosci 58:507–516. https://doi.org/10.1007/s12031-016-0712-0 CrossRefGoogle Scholar